Who founded Aspero Medical?

Aspero Medical was founded by Mark Rentschler, Steven Edmundowicz, MD in 2019.

Who are Aspero Medical's investors?

Aspero Medical's investors include Creative Destruction Lab (CDL), Innosphere Ventures, Rockies Venture Adviser, Llc, Rockies Venture Club.

How much funding has Aspero Medical raised?

Aspero Medical has disclosed $580K raised across 1 round.

Where is Aspero Medical headquartered?

Aspero Medical is headquartered in Boulder, US.

Aspero Medical

Boulder, US · Founded 2019 · Delaware corporation · 5 known investors

Find your way into Aspero Medical

Paths you didn't know you had: your email and LinkedIn already hold routes to the Aspero Medical team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aspero Medical develops the Pillar balloon overtube solution with micro-textured design to improve control and anchoring during balloon endoscopy for small bowel diagnosis and treatment. The technology reduces procedure time and sedation requirements for gastrointestinal interventions.

Deep Tech Healthtech Medical Devices

Founders & leadership

Aspero Medical was founded in 2019 by Mark Rentschler and Steven Edmundowicz, MD.

Mark RentschlerFounding CEOMark Rentschler is a mechanical and biomedical engineering professor with over 20 years of experience in engineering consulting, medical device design, and surgical robotics, holding more than 30 U.S. patents. He is the Executive Officer and Director of Aspero Medical, which develops endoscopic balloon technologies for gastrointestinal interventions.

Steven Edmundowicz, MDCo-Founder, Chief Medical Officer

Board

Mike FreemanMember Board Of DirectorsGeneral Partner at Innosphere Ventures

Investors · 5

Creative Destruction Lab (CDL)listed by Creative Destruction Lab (CDL)Toronto · $50K – $250K

Innosphere Ventureslisted by Innosphere VenturesBoulder

How we know: Innosphere Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Rockies Venture Adviser, Llclisted by Rockies Venture Adviser, LlcDenver · $100K – $500K

How we know: Rockies Venture Adviser, Llc's portfolio page · Not right? Tell us

Rockies Venture Clublisted by Rockies Venture ClubDenver · $100K – $500K

Also in the syndicate · 1

Innosphere Fund

Reported raises · per SEC filings

Form D private placements

$580K disclosed across 1 round · 2019

▶$580KraisedOct 2019 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Mark RentschlerExecutive Officer, Director
Mike FreemanDirector

Offering amount: $830K
Amount sold: $580K
First sale: Sep 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Spiro MedicalSpiro Medical is a clinical-stage medical device company developing neuromodulation therapies for severe, uncontrolled asthma and other respiratory conditions. The company targets the neurological mechanisms underlying respiratory disease to provide treatment options for patients who have not benefited from conventional therapies.

Exero MedicalExero Medical develops the xBar system, which uses electrode sensors embedded in a standard surgical drain to non-invasively monitor post-operative tissue healing and detect anastomotic leaks after gastrointestinal surgery. The system provides healthcare providers with post-operative data to enable earlier detection of complications; it is currently limited to investigational use in the US.

GIE MedicalGIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel. It is conducting clinical trials in the United States aimed at offering gastroenterology patients sustained patency and fewer repeat treatments.

Companies working in the same space as Aspero Medical.

In the news

Aspero Medical Expands Team to Address Growing Product Development Programsprnewswire.com · Sep 2020

Frequently asked questions

What does Aspero Medical do?: Aspero Medical develops the Pillar balloon overtube solution with micro-textured design to improve control and anchoring during balloon endoscopy for small bowel diagnosis and treatment. The technology reduces procedure time and sedation requirements for gastrointestinal interventions.
Who founded Aspero Medical?: Aspero Medical was founded by Mark Rentschler, Steven Edmundowicz, MD in 2019.
Who are Aspero Medical's investors?: Aspero Medical's investors include Creative Destruction Lab (CDL), Innosphere Ventures, Rockies Venture Adviser, Llc, Rockies Venture Club.
How much funding has Aspero Medical raised?: Aspero Medical has disclosed $580K raised across 1 round.
Where is Aspero Medical headquartered?: Aspero Medical is headquartered in Boulder, US.